Profession Notes

For the first time ever, the Howard Hughes Medical Institute (HHMI) wants to support M.D.s who aim to bridge basic science and clinical research. HHMI has opened a national competition to recruit up to 10 investigators who hold M.D.s or M.D.s plus Ph.D.s for patient-oriented research. Nomination invitations were sent to 119 institutions, including medical schools, research institutes, schools of public health, and selected independent hospitals. A committee of distinguished scientists will choos

Written byJean Mccann
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
For the first time ever, the Howard Hughes Medical Institute (HHMI) wants to support M.D.s who aim to bridge basic science and clinical research. HHMI has opened a national competition to recruit up to 10 investigators who hold M.D.s or M.D.s plus Ph.D.s for patient-oriented research. Nomination invitations were sent to 119 institutions, including medical schools, research institutes, schools of public health, and selected independent hospitals. A committee of distinguished scientists will choose investigators from tenured faculty members at those institutions with whom HHMI will then collaborate. "We will be looking for researchers who show the greatest potential for being able to translate basic science discoveries into useful clinical applications," says Thomas R. Cech, HHMI president. "There has been a steady decline in the number of physician-scientists who are pursuing careers that integrate direct patient contact and fundamental biomedical research." Patient-oriented research has grown in importance because of the Human Genome Project and other major advances in biomedical research, Cech adds. HHMI supports 340 investigators, but HHMI spokesman Jim Keeley notes only about 20 investigators do patient-oriented research. HHMI research expenditures this year are expected to reach about $500 million. In addition to grants to researchers, the institute also funds science education in this country, as well as supporting the research of a select group of scientists in other countries.
--Jean McCann

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies